Paul K Mohabir, MD
Critical Care (Intensivists) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mohabir’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A81363 · Current
Licensed to practise in California · since 2002 · expires 2028-03-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$107,254
Medicare paid this office $107,254 for 240 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 159 | $83,928 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $11,623 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,408 | $142 |
| Critical care, each additional 30 minutes | 14 | $1,964 | $94 |
| Test to measure expiratory airflow and volume | 32 | $702 | $7 |
Who their Medicare patients are
240 Original Medicare patients in 2024. Average age 69 · Under 65 22% · 85 and older 14% · Women 55% · Also on Medicaid 43% · Health risk score 3.09. Above the middle of the specialty; the typical critical care (intensivists) clinician is at 2.58.
Conditions among them: High blood pressure 75% · Diabetes 45% · Coronary heart disease 45% · Chronic kidney disease 41% · Heart failure 40% · Atrial fibrillation 39% · COPD 35% · Depression 35% · Stroke 29% · Dementia 28% · Cancer 22%.
The office billed $963,618, Medicare allowed $135,653 and paid $107,254; for 772 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 240 | 772 | 69 | 3.09 | $963,618 | $107,254 |
| 2023 | 183 | 659 | 69 | 3.32 | $912,986 | $99,716 |
| 2022 | 189 | 742 | 69 | 2.84 | $981,783 | $113,314 |
| 2021 | 184 | 630 | 70 | 2.82 | $846,928 | $96,141 |
| 2020 | 174 | 707 | 70 | 3.20 | $791,597 | $104,691 |
| 2019 | 251 | 848 | 69 | 2.96 | $647,603 | $100,865 |
| 2018 | 218 | 803 | 68 | 3.03 | $671,190 | $98,997 |
| 2017 | 243 | 831 | 69 | 2.60 | $819,314 | $114,488 |
| 2016 | 261 | 923 | 70 | 2.55 | $920,652 | $126,170 |
| 2015 | 325 | 1,032 | 70 | 2.53 | $758,791 | $124,670 |
| 2014 | 365 | 1,421 | 69 | 2.20 | $655,203 | $120,376 |
| 2013 | 263 | 942 | 68 | 2.30 | $672,052 | $116,845 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Critical care, first 30-74 minutes | 130 | $89,224 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $4,498 | $107 |
| Test to measure expiratory airflow and volume | 27 | $726 | $7 |
2022: 5 services
| Critical care, first 30-74 minutes | 148 | $97,057 | $195 |
| Long return visit (40+ min) | 25 | $7,517 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $3,283 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,571 | $65 |
| Test to measure expiratory airflow and volume | 24 | $658 | $8 |
2021: 6 services
| Critical care, first 30-74 minutes | 148 | $83,150 | $197 |
| Critical care, each additional 30 minutes | 13 | $3,404 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $3,365 | $93 |
| Long return visit (40+ min) | 17 | $2,861 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $863 | $66 |
| Test to measure expiratory airflow and volume | 28 | $625 | $8 |
2020: 8 services
| Critical care, first 30-74 minutes | 121 | $77,678 | $203 |
| Long return visit (40+ min) | 27 | $8,449 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $7,141 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,646 | $156 |
| Critical care, each additional 30 minutes | 14 | $2,337 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,874 | $67 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,107 | $101 |
| Test to measure expiratory airflow and volume | 27 | $427 | $8 |
2019: 8 services
| Critical care, first 30-74 minutes | 133 | $65,429 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $9,716 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 50 | $6,733 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,323 | $184 |
| Long return visit (40+ min) | 24 | $3,369 | $91 |
| Hospital discharge day management, more than 30 minutes | 28 | $3,173 | $99 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,486 | $68 |
| Test to measure expiratory airflow and volume | 35 | $1,049 | $8 |
2018: 6 services
| Critical care, first 30-74 minutes | 135 | $69,365 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $9,717 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $6,458 | $175 |
| Long return visit (40+ min) | 39 | $5,837 | $91 |
| Hospital discharge day management, more than 30 minutes | 25 | $2,778 | $96 |
| Test to measure expiratory airflow and volume | 32 | $1,126 | $7 |
2017: 6 services
| Critical care, first 30-74 minutes | 172 | $91,833 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $7,852 | $93 |
| Long return visit (40+ min) | 29 | $4,187 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,863 | $179 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,375 | $98 |
| Test to measure expiratory airflow and volume | 34 | $1,055 | $8 |
2016: 5 services
| Critical care, first 30-74 minutes | 187 | $100,126 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $7,778 | $92 |
| Long return visit (40+ min) | 48 | $7,033 | $88 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,907 | $95 |
| Test to measure expiratory airflow and volume | 33 | $1,009 | $8 |
2015: 9 services
| Critical care, first 30-74 minutes | 169 | $85,849 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $15,889 | $93 |
| Long return visit (40+ min) | 51 | $7,844 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $6,526 | $181 |
| Hospital discharge day management, more than 30 minutes | 26 | $2,740 | $98 |
| Test to measure expiratory airflow and volume | 28 | $880 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $842 | $65 |
| Test to measure expiratory airflow and volume | 47 | $387 | $7 |
| Test to examine how well the lungs exchange gases | 43 | $344 | $7 |
2014: 13 services
| Critical care, first 30-74 minutes | 130 | $72,119 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $15,980 | $92 |
| Long return visit (40+ min) | 49 | $8,483 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $6,835 | $180 |
| Hospital discharge day management, more than 30 minutes | 28 | $3,614 | $95 |
| Test to examine how well the lungs exchange gases | 149 | $1,748 | $8 |
| Test to measure expiratory airflow and volume | 149 | $1,734 | $7 |
| New patient visit (60+ min) | 12 | $1,680 | $140 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,409 | $64 |
| Pulmonary exercise testing | 47 | $1,305 | $27 |
| Test to measure expiratory airflow and volume | 25 | $765 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 18 | $211 | $12 |
| Test to determine lung volumes using sensors | 17 | $199 | $11 |
2013: 10 services
| Critical care, first 30-74 minutes | 146 | $79,997 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $11,807 | $89 |
| Long return visit (40+ min) | 51 | $8,467 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,406 | $163 |
| Critical care, each additional 30 minutes | 11 | $3,069 | $96 |
| Hospital discharge day management, 30 minutes or less | 35 | $2,296 | $64 |
| New patient visit (60+ min) | 13 | $1,884 | $145 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,117 | $62 |
| Test to measure expiratory airflow and volume | 23 | $776 | $7 |
| Pulmonary exercise testing | 18 | $474 | $26 |
Medicaid work
$20,965 in 2024
Medicaid paid $20,965 for 315 billed services this clinician did in 2024, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 212 | $18,362 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 63 | $2,353 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 40 | $250 |
| 2024 | 315 | 3 | 19 | $20,965 |
| 2023 | 667 | 3 | 27 | $52,762 |
| 2022 | 454 | 3 | 25 | $34,923 |
| 2021 | 429 | 3 | 35 | $46,678 |
| 2020 | 427 | 6 | 22 | $33,439 |
| 2019 | 300 | 3 | 20 | $27,018 |
| 2018 | 181 | 3 | 17 | $13,637 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 524 | $50,820 |
| Long return visit (40+ min) | 16 | $1,059 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 127 | $882 |
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 354 | $32,243 |
| Long return visit (40+ min) | 48 | $2,187 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 52 | $494 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 389 | $45,885 |
| Long return visit (40+ min) | 12 | $594 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 28 | $198 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 292 | $28,213 |
| Long return visit (40+ min) | 43 | $2,861 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 52 | $1,319 |
| 1ST HOSP IP/OBS HIGH 75 | 13 | $582 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 13 | $340 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 14 | $124 |
2019
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 205 | $23,877 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 55 | $1,835 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 40 | $1,305 |
2018
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 93 | $10,108 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 47 | $3,219 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 41 | $310 |
Money from drug and device companies
$8,440 in 2025
| 2025 | 1 | 6 | $7,935 | $8,440 |
| 2021 | 3 | 3 | $2,750 | $2,764 |
| 2020 | 1 | 1 | $410 | $410 |
| 2019 | 1 | 1 | $410 | $410 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Vertex Pharmaceuticals | Alyftrek | $8,440 | 6 payments
|
See all 6 published payments
| Vertex Pharmaceuticals | Meals · 2025-12-10 | None | $77 |
| Vertex Pharmaceuticals | Travel · 2025-12-10 | None | $304 |
| Vertex Pharmaceuticals | Paid to speak or teach · 2025-12-10 | None | $6,555 |
| Vertex Pharmaceuticals | Meals · 2025-11-19 | None | $10 |
| Vertex Pharmaceuticals | Meals · 2025-11-18 | None | $115 |
| Vertex Pharmaceuticals | Consulting · 2025-06-25 | Alyftrek | $1,380 |
See earlier years (2021, 2020, 2019)
2021: $2,764
| Mylan Specialty L.P. | Tobi Podhaler | $2,500 | 1 payment
|
| Merck Sharp & Dohme | None | $250 | 1 payment
|
| Chiesi USA | Bronchitol | $14 | 1 payment
|
2020: $410
| Merck Sharp & Dohme | None | $410 | 1 payment
|
2019: $410
| Merck Sharp & Dohme | None | $410 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Boehringer Ingelheim Pharmaceuticals, Inc. · Systemic Sclerosis Ild Pivotal Study · 2019 | Their institution | $11,177 |
| Boehringer Ingelheim Pharmaceuticals, Inc. · Systemic Sclerosis Ild Pivotal Study · 2020 | Their institution | $3,055 |
| Boehringer Ingelheim Pharma GmbH & Co.KG · Systemic Sclerosis (Ild) Pivotal Study · 2019 | Their institution | $119 |
| Boehringer Ingelheim Pharma GmbH & Co.KG · Extension · 2019 | Their institution | $12 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1811909708
- Licence
- CA A81363California A81363: Current · expires 2028-03-31
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A813630
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Federal specialty code 207RC0200X (207RC0200X)
- Mailing address
- Stanford University School of Medicine, 300 Pasteur Dr, H3143, Stanford, CA, 94305
- NPI first listed
- 2006-08-12
- NPI last updated
- 2019-08-08
This is when the NPI record was last certified, not a medical board exam.